331A — Medix Balance Sheet
0.000.00%
Annual balance sheet for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 2,364 | 2,780 | 3,771 | 4,064 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 2,242 | 2,293 | 2,227 | 2,548 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 4,715 | 5,175 | 6,102 | 6,747 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 112 | 132 | 115 | 122 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 5,432 | 5,904 | 6,670 | 7,732 |
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 2,962 | 3,125 | 2,833 | 3,077 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Funded Status | ||||
| Total Liabilities | 3,702 | 3,747 | 3,401 | 4,296 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Unrealized Gain / Loss | ||||
| Other Equity | ||||
| Total Equity | 1,730 | 2,157 | 3,269 | 3,437 |
| Total Liabilities & Shareholders' Equity | 5,432 | 5,904 | 6,670 | 7,732 |
| Total Common Shares Outstanding |